Anokion raises USD 35m Financing

Anokion SA, a clinical-stage biotechnology company focused on treating autoimmune disease by restoring normal immune tolerance, recently closed an USD 35 million equity investment from Pfizer through the Pfizer Breakthrough Growth Initiative.

VISCHER acted as legal advisor to Anokion in this transaction. The team included Matthias Staehelin, Vincent Reardon and Luzius Zumstein (all Corporate/M&A).

Categories: Corporate and Commercial, Life Sciences, Pharma, Biotech, Private Equity & Venture Capital, Startup Desk

Matthias Staehelin

Attorney at Law and Civil Law Notary (BS/BL)

• Partner

• +41 58 211 33 53
• mstaehelin@vischer.com

Vincent S. Reardon

Attorney at Law

• Managing Associate

• +41 58 211 32 40
• vreardon@vischer.com

Luzius Zumstein

Attorney at Law

• Managing Associate

• +41 58 211 32 02
• lzumstein@vischer.com